(NASDAQ:CMND),(Frankfurt:CWY0), Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate Vancouver, Canada, Nov. 20, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived […]

Exponential Science (ES) announced today the launch of theES Accelerator, a founder-focused programme powered by venture builder H-FARM – ranked among the Financial Times' Top 10 European Startup Hubs – and designed to support ambitious early-stage companies leveraging exponential technologies, including distributed ledger technology (DLT), artificial intelligence, and quantum computing, to build an equitable and

— Black Friday deals at Target begin this Sunday, Nov. 23, with savings of up to 50% off across top categories — Exclusive product launches and surprise giveaways will make Black Friday shopping at Target more joyful than ever — The first 100 Black Friday shoppers at every store will receive a tote packed with

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site GlobeNewswire November 20, 2025 Prestigious Hadassah Medical Center Joins Yale, Johns Hopkins, Tel Aviv Sourasky and IMCA, in Evaluating the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate Vancouver, Canada, Nov. 20, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq:

(OtherOTC:CINV), LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) — Crucial Innovations Corp., a pioneering medical cannabis company, announced the signing of a Management Services Agreement (MSA) with Cannabudgrow (Pty) Ltd (“CBG”), a licensed cultivator and exporter of medicinal cannabis based in Johannesburg, South Africa. Under the terms of the agreement, Crucial Innovations will provide CBG with

TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — More than 300 clinicians, researchers, and decision makers from across Canada gathered in Toronto on November 18-19 for the fourth annual bioMerieux Canada Antimicrobial Resistance (AMR) Symposium. Under the theme “Preserving Antimicrobial Effectiveness: Acting Today for Future Generations,” the two-day event showcased the latest science, innovations, and public-health

Fulton, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) — Sonatype(R), the leader in AI-driven DevSecOps, today released a new report, “Trust Issues: The CVE Crisis,” revealing that the world's most widely used vulnerability index — the Common Vulnerabilities and Exposures (CVE) system — struggles to keep pace with the realities of modern software development. The study

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) — Nine in ten U.S. adults say the nation is facing a mental health crisis, and experts, parents and policymakers are increasingly concerned about the rise of generative-AI therapy chatbots. For Matthew and Maria Raine, the danger became devastatingly real this April when their son, Adam, took his

(TSX:OM),(Boerse Frankfurt – Freiverkehr:0B51),(OTC US:OMZNF),(Other OTC:OMZNF), MONTREAL, Nov. 20, 2025 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce new drill results from the Gaspe Copper Project, located in the Gaspe Peninsula of Eastern Quebec. Osisko Metals CEO Robert Wares commented: “These latest

(NYSE:KBR), HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) and Axiom Space successfully completed the first uncrewed thermal vacuum test of the Axiom Extravehicular Mobility Unit (AxEMU) Pressure Garment, which is designed to support astronauts during the Artemis III mission – the first crewed lunar landing in more than 50 years. The test